Evaluation of the effect of Kefir produced from cow's milk on the treatment process and immune response of patients with Corona virus 2019 (COVID-19
Not Applicable
- Conditions
- COVID-19.Coronavirus infection, unspecifiedB34.2
- Registration Number
- IRCT20221106056423N1
- Lead Sponsor
- Artesh University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Positive PCR-test confirming COVID-19 infection
Having a moderate or severe level of the disease
ICU patients (provided that there is no restriction on the consumption of certain food substances)
Age between 20-60 years
Administering 2 doses of Sinopharm vaccine
Absence of food allergies
Exclusion Criteria
Pregnancy or lactating
Use of anti-coagulant drugs
No infection with the Covid-19 virus
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fever. Timepoint: At the baseline and end of the intervention. Method of measurement: Thermometer.;C-Reactive Protein. Timepoint: At the baseline and end of the intervention. Method of measurement: kit (Bionik, Iran) with the BT3500 (Biotecnica Instruments SpA -Italy) auto-analyzer.;Erythrocyte Sedimentation Rate (ESR). Timepoint: At the baseline and end of the intervention. Method of measurement: Westergren Method.;Dyspnea. Timepoint: At the baseline and end of the intervention. Method of measurement: Clinical examintation.
- Secondary Outcome Measures
Name Time Method Gastrointestinal symptoms. Timepoint: At the baseline and the end of the intervention. Method of measurement: Clinical examination.;WBC. Timepoint: At the baseline and the end of the intervention. Method of measurement: Sysmex K-1000 Hematology Analyzer.